RAF1 and cancer: They can specifically inhibit BRAFV600E monomers in BRAF mutant cancer cells, but in RAF WT cells, their binding to RAF induces RAF dimerization and allosteric transactivation of the second protomer, leading to paradoxical ERK signaling activation.430,431